STAT1 and psoriasis: In addition, MSCs suppress Th17 cell differentiation through IFN-γ-mediated STAT1 activation, which upregulates SOCS3 and inhibits STAT3 signaling, ultimately exerting immunomodulatory effects in autoimmune diseases, including psoriasis [112].